As a first screen, we measured GCase activity in iPSC-derived neurons carrying mutations in different PD genes, i.e., GBA1 (L444P), LRRK2 (G2019S) and compared to five different healthy controls. This evidence concerns the gene GBA1 and Parkinson disease.